arrow_back Back to App

DIPG Awareness Day: Supporting Pediatric Brain Cancer Research

The U.S. House of Representatives supports designating May 17, 2025, as DIPG Awareness Day. This aims to raise awareness about diffuse intrinsic pontine glioma (DIPG), a rare and fatal pediatric brain cancer, and encourage research into cures. The initiative seeks to highlight the need for increased funding for pediatric cancer research, offering hope to affected families.
Key points
Designation of May 17, 2025, as DIPG Awareness Day to increase public awareness of this rare pediatric brain tumor.
Encouragement for increased funding for research into DIPG and other pediatric cancers, potentially leading to new treatments.
Emphasis on considering mortality rates and years of life lost when evaluating research funding applications to support critical areas.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_419
Sponsor: Rep. Dingell, Debbie [D-MI-6]
Process start date: 2025-05-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_419.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-05-15.

What are the main provisions?

Key points include:

  • Designation of May 17, 2025, as DIPG Awareness Day to increase public awareness of this rare pediatric brain tumor.
  • Encouragement for increased funding for research into DIPG and other pediatric cancers, potentially leading to new treatments.
  • Emphasis on considering mortality rates and years of life lost when evaluating research funding applications to support critical areas.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dingell, Debbie [D-MI-6].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health